Perioperative Oral Vitamin D3 Supplementation on Implant Osseointegration
ConditionImplant Site Reaction
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorNantes University Hospital
About this trial
The number of patients treated in Implantology at Nantes University Hospital is 400 per year. This pilot study aims to demonstrate the efficacy of a 6-month oral cholecalciferol supplementation on osseointegration in patients requiring dental implants and presenting with vitamin D deficiency, compared to French patients who have not undergone vitamin D screening
Eligibility criteria
Qualifiers
Male or female patient ≥ 18 years old, candidate for dental implant placement.
with vitamin D deficiency or insufficiency: 25(OH)D < 25 ng/L.
affiliated with a social security scheme.
Disqualifiers
with a local contraindication for implant placement.
under guardianship, curatorship, or legal protection
Pregnant or breastfeeding women
Trial design
Treatments tested in this trial
- Not listed
Trial groups
60 Participants
are grouped into 1 trial groupSponsors and collaborators
Source ClinicalTrials.gov